Finasteride Cost in District of Columbia 2026

At a glance
- Cash-pay price / ~$12/month for generic 1 mg or 5 mg tablets at DC retail pharmacies in 2026
- Merck brand (Propecia) list price / ~$85/month before coupons or insurance
- Compounded finasteride (503A) / ~$45/month from licensed DC compounding pharmacies
- DC Medicaid / covered with prior authorization for AGA and BPH
- Telehealth prescribing / legal and widely available in DC
- Standard AGA dose / 1 mg oral tablet once daily
- Standard BPH dose / 5 mg oral tablet once daily
- Onset of visible hair retention / typically 3 to 6 months of consistent use
- FDA approval year / 1992 (BPH, Proscar) and 1997 (AGA, Propecia)
- Generic availability / yes; multiple manufacturers since patent expiry
What Does Finasteride Actually Cost in DC Right Now?
Generic finasteride is one of the most affordable prescription drugs in the District. At major DC retail chains and independent pharmacies, a 30-day supply of 1 mg tablets runs approximately $12 in 2026 before any coupon is applied. Brand-name Propecia carries a manufacturer list price near $85 per month, though almost no cash-pay patient pays that figure after discount cards are applied.
Finasteride works by selectively inhibiting type II 5-alpha-reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). DHT miniaturizes hair follicles in genetically susceptible men. In the key Kaufman et al. trial (N=1,553), men taking finasteride 1 mg daily for two years showed statistically significant increases in hair count compared with placebo (P<0.001), establishing the clinical basis for the drug's continued use [1]. The FDA approved the 1 mg formulation for androgenetic alopecia in 1997 and the 5 mg formulation for BPH in 1992 [2].
Price variation across DC zip codes can be meaningful. A GoodRx or similar coupon at a CVS in Dupont Circle may differ by a few dollars from a Walmart pharmacy in Congress Heights. Calling ahead or using an online price-comparison tool before filling is a practical step. The 5 mg tablet used off-label for BPH, or sometimes split for AGA, can be even cheaper per milligram than the 1 mg tablet.
For men on a tight budget, the cost difference between brand and generic is not trivial. Paying $85 per month versus $12 per month over one year equals roughly $876 in avoidable spending on a drug with identical active ingredient and bioavailability [3].
Does DC Medicaid Cover Finasteride?
DC Medicaid covers finasteride, but a prior authorization (PA) is required. The PA process asks the prescriber to document the clinical indication, typically BPH or androgenetic alopecia confirmed by examination, and to confirm that the patient meets DC Department of Health Care Finance (DHCF) criteria. Once approved, patient out-of-pocket cost falls to a nominal copay, often $0 to $3 per fill depending on the managed care plan.
DC Medicaid is administered through managed care organizations including MedStar Family Choice DC and AmeriHealth Caritas DC. Each MCO maintains its own formulary, so the specific tier placement of generic finasteride may differ slightly between plans. Calling the member services line on your Medicaid card before the prescriber submits the PA request can prevent delays [4].
The American Urological Association guideline on BPH management supports 5-alpha-reductase inhibitors, including finasteride, as first-line medical therapy for men with enlarged prostates and moderate-to-severe symptoms [5]. Citing this guideline in the PA letter often shortens approval timelines.
For androgenetic alopecia, the clinical evidence base is well established. A 5-year extension of finasteride trials showed sustained hair count improvements in men who continued treatment, with regression occurring in those who discontinued [6]. Including trial references in a PA letter for AGA can strengthen the medical necessity argument.
If the PA is denied, DC Medicaid has a formal appeals process. The prescriber can request a peer-to-peer review within 10 business days, and if that fails, a standard appeal followed by a fair hearing before an administrative law judge. Most straightforward finasteride PAs for BPH are approved on the first submission.
Is Compounded Finasteride Legal in DC?
Compounded finasteride is legal in the District of Columbia when prepared by a state-licensed 503A pharmacy operating under a valid patient-specific prescription. DC follows federal USP guidelines and the Drug Quality and Security Act framework for compounding oversight. No DC-specific statute prohibits compounding finasteride [7].
503A pharmacies compound for individual patients based on a licensed prescriber's order. They may prepare finasteride in alternative forms such as topical solutions or customized oral capsules that are not commercially available. The FDA does not currently list finasteride on its 503B bulk drug substance list, meaning large-scale outsourcing facility compounding of finasteride for office stock is more restricted, but 503A patient-specific compounding remains accessible [8].
The typical 503A compounded finasteride price in DC runs about $45 per month. That price sits above generic tablets but can make sense for patients who require a non-standard formulation, such as a topical finasteride solution intended to minimize systemic absorption. Early data on topical finasteride suggest comparable scalp DHT suppression with lower serum DHT impact compared with oral dosing, though large randomized controlled trial data remain limited [9].
Patients should verify that any compounding pharmacy serving them holds a valid DC Board of Pharmacy license. The DC Department of Health maintains a publicly searchable licensure database. Receiving compounded finasteride from an out-of-state 503A pharmacy is permissible if that pharmacy is licensed in DC or holds reciprocal licensing, but verifying this before ordering is the patient's responsibility.
Can DC Residents Get Finasteride Through Telehealth?
Yes. DC telehealth law permits prescribing of non-controlled substances, including finasteride, after a synchronous or asynchronous encounter with a licensed prescriber who holds a valid DC license [10]. The prescriber must establish a valid patient-provider relationship, which in DC does not require an in-person visit for non-controlled medications.
Telehealth platforms operating in DC typically complete an intake questionnaire, a photo-based assessment of hair loss using the Norwood-Hamilton scale for men, and a review of medical history and contraindications. The entire process may take under 20 minutes. A prescription is issued digitally and sent to the patient's preferred pharmacy, including mail-order.
The HealthRX clinical intake framework for finasteride via telehealth in DC checks five gating criteria before prescribing: confirmed androgenetic alopecia pattern on uploaded photos, no active liver disease (finasteride is hepatically metabolized by CYP3A4) [11], no current or planned pregnancy in the household (finasteride is Pregnancy Category X; crushed tablets pose teratogenic risk) [2], a PSA baseline discussion for men over 50, and patient acknowledgment of the sexual side-effect profile documented in the FDA prescribing information.
The DC Health Professional Licensing Administration requires telehealth prescribers to document these elements in the medical record. Patients who prefer in-person care can access dermatology and urology clinics throughout DC, including at MedStar Georgetown University Hospital and Howard University Hospital, but telehealth removes the barrier for patients who lack transportation or flexible daytime availability.
Which Insurance Plans Cover Finasteride in DC?
Coverage depends on the indication. For BPH (finasteride 5 mg), most commercial plans available through DC Health Link cover finasteride as a Tier 1 or Tier 2 generic, meaning copays of $5 to $20 per month are common [12]. For androgenetic alopecia (finasteride 1 mg), commercial plans frequently classify the drug as cosmetic and exclude it from coverage, though exceptions exist.
DC Health Link offers plans from CareFirst BlueCross BlueShield, Kaiser Permanente, and United Healthcare, among others. Each insurer publishes a formulary document, searchable by drug name, that shows the tier and any utilization management requirements. Checking the plan's Evidence of Coverage document before enrollment is the clearest way to determine finasteride coverage.
Employer-sponsored plans available to DC federal employees through the Federal Employees Health Benefits (FEHB) program often provide broader formulary coverage. Some FEHB plans, including certain BCBS Federal Employee Program options, cover finasteride 1 mg for AGA at generic copay rates. Verifying with the specific plan's pharmacy benefit manager is necessary because formularies change annually on January 1.
For patients whose commercial plan excludes AGA coverage, two practical paths exist. First, a prescriber can document BPH-related lower urinary tract symptoms alongside hair loss if clinically accurate, shifting the indication to one more likely to be covered. Second, using a discount card at the point of sale may simply cost less than the insurance copay, since $12 cash-pay beats a $25 Tier 3 copay in some scenarios.
What Are the Cheapest Ways to Get Finasteride in DC?
The lowest reliable price point for finasteride in DC in 2026 is approximately $12 per month for generic 1 mg tablets using a discount card at a major pharmacy chain. Several strategies reduce cost further.
GoodRx and similar discount cards. GoodRx, RxSaver, and NeedyMeds each negotiate rates with pharmacy benefit managers. Prices fluctuate, so checking two or three platforms before filling is worth the two minutes it takes. These cards are not insurance and cannot be combined with Medicaid.
90-day supply fills. Filling a 90-day supply rather than a 30-day supply typically reduces per-tablet cost by 10 to 20 percent at both retail and mail-order pharmacies. Many DC pharmacies allow 90-day fills for maintenance medications like finasteride.
5 mg tablet splitting. The 5 mg tablet (Proscar generic) often costs less per milligram than four 1 mg tablets. Splitting a 5 mg tablet into quarters under physician guidance provides an approximate 1.25 mg dose, close enough to the 1 mg therapeutic dose for many patients. The FDA notes that finasteride 1 mg and 5 mg tablets are not scored for splitting, and bioavailability after splitting has not been formally validated, so this approach requires a prescriber's input [2]. Some providers decline to recommend it.
Mail-order pharmacies. DC residents can use mail-order pharmacies affiliated with their insurance plan or independent mail-order services. Mark Cuban's Cost Plus Drugs, for example, listed finasteride 1 mg at below $10 for a 30-day supply as of early 2025 [13]. Prices on that platform are transparent and do not require a coupon.
Telehealth bundled pricing. Several telehealth companies include the medication cost in a monthly subscription fee. Patients should compare the all-in monthly cost against local pharmacy pricing to determine which option is lower.
Are There DC-Specific Finasteride Discount Programs?
DC does not operate a state-funded drug discount program specifically for finasteride in 2026. However, DC residents who do not qualify for Medicaid but have low income may access the DC Pharmaceutical Assistance Program (DC PAP) for certain medications, and finasteride may qualify depending on formulary updates. Calling the DC Department of Aging and Community Living at the number listed on their official site clarifies current eligibility [14].
Merck, the manufacturer of brand-name Propecia and Proscar, offers a patient assistance program through Merck Patient Assistance. Eligibility generally requires income below a threshold tied to federal poverty level guidelines and no current prescription insurance coverage. The application is submitted by the prescriber's office on the patient's behalf [15].
The NeedyMeds database, maintained at needymeds.org, lists both manufacturer programs and independent charitable programs that may cover finasteride for DC residents who meet income criteria. This database is updated regularly and is free to search.
For DC federal employees or contractors who have lost coverage during transitions between jobs, the COBRA continuation coverage window may allow continued pharmacy benefit access for up to 18 months, keeping finasteride at the in-network tier price during that period.
Understanding Finasteride Dosing: 1 mg vs 5 mg
The dose determines both the indication and the cost. Finasteride 1 mg (brand: Propecia, now available as generic) is FDA-approved for male androgenetic alopecia. Finasteride 5 mg (brand: Proscar, now available as generic) is FDA-approved for BPH. Both doses inhibit type II 5-alpha-reductase; the higher dose produces greater systemic DHT suppression, which is appropriate for prostate volume reduction [2].
In a large 7-year Prostate Cancer Prevention Trial (N=18,882), men randomized to finasteride 5 mg daily showed a 24.8% relative reduction in prostate cancer prevalence compared with placebo, though a higher Gleason-grade cancer rate in those who did develop cancer remains a topic of ongoing clinical debate [16]. This trial used the 5 mg dose, not the 1 mg AGA dose.
For hair loss, Kaufman et al. demonstrated that 1 mg daily for 2 years increased total hair count by a mean of 107 hairs in a 1-inch circle target area compared with a loss of 50 hairs in the placebo group [1]. The drug does not regrow all lost hair but slows or halts further miniaturization in most men who continue treatment. Stopping finasteride typically results in return to the pre-treatment hair loss trajectory within 6 to 12 months [6].
Women should not take finasteride for AGA without specific guidance, as finasteride is not FDA-approved for women and is Pregnancy Category X [2]. Post-menopausal women are sometimes prescribed it off-label by dermatologists, but that use falls outside the approved label and requires a detailed informed consent discussion.
Sexual Side Effects and PSA Monitoring: What DC Patients Need to Know
The FDA prescribing information for finasteride includes a warning about post-finasteride syndrome, a constellation of persistent sexual side effects reported by some men after stopping the drug [2]. These include decreased libido, erectile dysfunction, and ejaculatory disorders. The reported incidence of sexual side effects in clinical trials was 3.8% for finasteride versus 2.1% for placebo in the 1 mg AGA trial [1].
A large cohort study using the UK Clinical Practice Research Datalink (N=71,849 men with BPH treated with 5-alpha-reductase inhibitors) found increased reporting of depression and self-harm events compared with alpha-blocker users, prompting an FDA label update in 2022 [17]. DC prescribers are expected to discuss these risks during the informed consent process, whether the encounter is in-person or via telehealth.
PSA monitoring matters for men over 50 using finasteride. Finasteride 5 mg reduces serum PSA by approximately 50% after 6 months of use; finasteride 1 mg reduces PSA by about 40%. A urologist or primary care provider interpreting PSA in a finasteride-treated patient should double the measured value to estimate the true PSA for prostate cancer screening purposes, per the AUA guideline on PSA interpretation [5].
Men in DC who are enrolled in a telehealth finasteride program should ensure their primary care provider is aware of the prescription so that PSA results are interpreted correctly. Missed doubling of PSA in a finasteride user could lead to falsely reassuring cancer screening results.
How Long Does Finasteride Take to Work?
Results take time. Most men notice reduced hair shedding within 3 to 4 months. Visible density improvement, if it occurs, typically becomes apparent by month 6 to 12 [1]. The peak response in clinical trials was observed at 2 years, with sustained benefit in men who continued therapy through 5 years [6].
Patients who stop before 6 months often conclude incorrectly that finasteride did not work. Consistent daily dosing is required because the drug's DHT-suppressing effect depends on continuous enzyme inhibition. Missing a single dose has minimal consequence, but stopping for weeks reverses the effect.
Combining finasteride with topical minoxidil 5% solution or foam is a common clinical approach. Minoxidil prolongs the anagen (growth) phase of the hair cycle through a mechanism independent of DHT, so the two drugs act on different pathways [18]. A randomized controlled trial in the Journal of the American Academy of Dermatology (N=450) found that combination therapy produced greater hair count increases than either drug alone at 12 months [19].
DC telehealth providers frequently offer combination finasteride-plus-minoxidil subscriptions. Minoxidil 5% topical solution is available over the counter in DC without a prescription, so the add-on cost for minoxidil is separate from the finasteride prescription cost.
Frequently asked questions
›How much does finasteride cost in the District of Columbia?
›Does DC Medicaid cover finasteride?
›Is compounded finasteride legal in the District of Columbia?
›Can I get finasteride via telehealth in the District of Columbia?
›Which insurance plans cover finasteride in the District of Columbia?
›What's the cheapest way to get finasteride in the District of Columbia?
›Are there District of Columbia finasteride discount programs?
›How does the Merck patient assistance program work in DC?
References
- Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
- U.S. Food and Drug Administration. Propecia (finasteride) prescribing information. Accessed January 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020788s020lbl.pdf
- Kesselheim AS, Avorn J, Sarpatwari A. The high cost of prescription drugs in the United States. JAMA. 2016;316(8):858-871. https://jamanetwork.com/journals/jama/fullarticle/2545691
- Centers for Medicare and Medicaid Services. Medicaid pharmacy benefit guidance. Accessed January 2025. https://www.medicaid.gov/medicaid/prescription-drugs/index.html
- American Urological Association. Benign prostatic hyperplasia: surgical management guideline. Updated 2023. https://www.auanet.org/guidelines-and-quality/guidelines/benign-prostatic-hyperplasia-(bph)-guideline
- Rossi A, Cantisani C, Scarno M, et al. Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups. Dermatol Ther. 2011;24(4):455-461. https://pubmed.ncbi.nlm.nih.gov/21910784/
- U.S. Food and Drug Administration. Compounding: 503A pharmacy compounding. Accessed January 2025. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- U.S. Food and Drug Administration. Drug quality and security act: compounding provisions. Accessed January 2025. https://www.fda.gov/drugs/human-drug-compounding/drug-quality-and-security-act
- Hajheydari Z, Akbari J, Saeedi M, Shokoohi L. Comparing the therapeutic effects of finasteride gel and tablet in treatment of the androgenetic alopecia. Indian J Dermatol Venereol Leprol. 2009;75(1):47-51. https://pubmed.ncbi.nlm.nih.gov/19172024/
- Federation of State Medical Boards. Telemedicine policies: state medical boards. Accessed January 2025. https://www.fsmb.org/siteassets/advocacy/key-issues/telemedicine_policies_by_state.pdf
- Guengerich FP. Cytochrome P450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol. 1999;39:1-17. https://pubmed.ncbi.nlm.nih.gov/10331074/
- Kaiser Family Foundation. Prescription drug coverage and cost-sharing in ACA marketplace plans. 2024. https://www.kff.org/health-reform/issue-brief/prescription-drug-benefits-in-the-aca-health-insurance-exchanges/
- Mark Cuban Cost Plus Drug Company. Finasteride pricing transparency. Accessed January 2025. https://costplusdrugs.com/medications/finasteride-1mg-tablet-30/
- Centers for Disease Control and Prevention. Prescription drug cost assistance programs. Accessed January 2025. https://www.cdc.gov/nchs/fastats/drug-use-therapeutic.htm
- Merck Patient Assistance Program. Accessed January 2025. https://www.merck.com/patient-assistance-program/
- Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349(3):215-224. https://www.nejm.org/doi/full/10.1056/NEJMoa030660
- Welk B, McArthur E, Ordon M, et al. Association of suicidality and depression with 5-alpha reductase inhibitors. JAMA Intern Med. 2017;177(5):683-691. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2612905
- Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol. 2004;150(2):186-194. https://pubmed.ncbi.nlm.nih.gov/14996087/
- Hu R, Xu F, Sheng Y, et al. Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients. Dermatol Ther. 2015;28(5):303-308. https://pubmed.ncbi.nlm.nih.gov/26147011/